Return to search

Uticaj subhroničnog tretmana akrilamidom na histološke i biohemijske karakteristike jetre juvenilnih mužjaka pacova / Histological and biochemical features of theliver in juvenile male rats following subchronicacrlyamide exposure

<p>Akrilamid (CASR No. 79-06-1) predstavlja veoma reaktivni, hidrosolubilni&nbsp;monomer za koji se smatra da ima toksične i potencijalno kancerogene efekte po&nbsp;zdravlje ljudi. &Scaron;tetne posledice akrilamida i njegovog jo&scaron; reaktivnijeg metabolita,&nbsp;glicidamida, su dokazane kod eksperimentalnih životinja i podrazumevale su&nbsp;neurotoksičnost, genotoksičnost i kancerogenost. Epidemiolo&scaron;ke studije rađene na&nbsp;ljudima pokazale su da akrilamid izaziva neurotoksične efekte, dok se genotoksičnost i&nbsp;kancerogenost jo&scaron; smatraju potencijalnim efektima, a zasnivaju se na podacima koji su&nbsp;dobijeni u okviru istraživanja na laboratorijskim životinjama. Njegove &scaron;tetne posledice&nbsp;na jetru, posebno kod mladog organizma, jo&scaron; uvek nisu dovoljno istražene.</p><p>Akrilamid se spontano formira u hrani koja je bogata ugljenim hidratima, tokom&nbsp;termičke obrade namirnica na visokim temperaturama. Ovaj monomer se formira&nbsp;tokom tzv. neenzimatske Mallard-ove reakcije, kojom se dobijaju smeđe komponente&nbsp;u hrani. U namirnicama ovaj monomer se formira reakcijom između redukujućih&nbsp;&scaron;ećera (uglavnom glukoze ili fruktoze) i aminokiseline (dominantno asparagina).</p><p>Imajući na umu da je jetra centralni organ za metabolizam akrilamida, ovo&nbsp;istraživanje &nbsp;je imalo za cilj da ispita glavne histolo&scaron;ke i biohemijske promene na jetri&nbsp;juvenilnog organizma pacova, nakon njegove subhronične ekspozicije akrilamidu.&nbsp;Istraživanje je &nbsp;rađeno na 3 eksperimentalne grupe peripubertalnih/juvenilnih mužjaka&nbsp;Wistar pacova, od kojih su dve bile tretirane vodenim rastvorom akrilamida u dozi od&nbsp;25 ili 50 &nbsp;mg/kg telesne mase, dok je treća grupa služila kao kontrola i primala&nbsp;destilovanu vodu. Životinje su bile tretirane oralno, putem gavaže, 5 dana nedeljno,&nbsp;tokom 3 nedelje. Nakon 24 h od poslednjeg tretmana, životinje su uvedene u etarsku &nbsp;anesteziju i dekapitovane, a zatim su prikupljeni krv i uzorci tkiva jetre.</p><p>Tkivo jetre je uzeto iz srednjeg lobusa, fiksirano u 10% neutralnom puferisanom &nbsp;formalinu tokom 24 h i obrađeno prema standardnom protokolu za parafinsko kalupljenje. Ukalupljeni uzorci jetre su zatim isečeni na serijske preseke tkiva debljine&nbsp;5 &micro;m, a zatim bojeni histohemijskim i imunohistohemijskim metodama. Uzorci krvi su&nbsp;pripremljeni za serolo&scaron;ku analizu.&nbsp;</p><p>Histolo&scaron;ka analiza preseka bojenih hematoksilin-eozin (H&amp;E) metodom nije &nbsp;zabeležila prisustvo značajnih razlika u op&scaron;toj arhitekturi jetre i njenoj lobularnoj &nbsp;organizaciji među eksperimentalnim grupama. Stereolo&scaron;ka analiza je ukazala na &nbsp;<br />mikrostrukturne promene kod hepatocita i jetrinih sinusoida. Rezultati sugeri&scaron;u, na&nbsp;dozno-zavisno povećanje volumena hepatocita, njihove citoplazme i nukleusa, i doznozavsino smanjenje volumena sinusoida, u odnosu na kontrolne uzorke jetre.</p><p>Analiza glikogena je rađena na presecima jetre bojenim metodom Periodic acid&ndash;<br />Schiff-a (PAS), gde se uočilo smanjenje količine glikogena u grupi tretiranoj nižom &nbsp;dozom akrilamida, dok je u grupi tretiranoj većom dozom uočena njegova&nbsp;<br />akumulacija, u odnosu na kontrolne životinje.</p><p>Imunopozitivnost hepatocita na marker proliferacije, Ki-67, bila je smanjena u&nbsp;grupi pacova tretiranoj nižom dozom, a bila povećana u grupi tretiranoj većom dozom&nbsp;akrilamida pri komparaciji sa kontrolom. Stereolo&scaron;ki nalazi su potvrdili inicijalnu&nbsp;histolo&scaron;ku analizu.</p><p>Imunopozitivnost hepatocita na marker apoptoze, Caspase 3, je bila smanjena&nbsp;<br />kod obe grupe životinja tretiranih akrilamidom u odnosu na kontrolu. Nasuprot tome,&nbsp;<br />imunopozitivnost neparenhimskih ćelija jetre, pretežno Kupffer-ovih ćelija, je bila&nbsp;<br />uvećana u obe tretirane grupe pri komparaciji sa kontrolom.</p><p>Imunopozitivnost Kupffer-ovih ćelija na marker CD68 je bila smanjena u&nbsp;uzorcima jetre kod oba tretmana akrilamidom u odnosu na kontrolu.</p><p>Populacija mastocita, prikazana toluidine-blue (TB) metodom bojenja, bila je&nbsp;uvećana &nbsp;kod obe grupe pacova tretiranih akrilamidom u poređenju sa kontrolom.&nbsp;Povećanje brojnosti ovih ćelija je bilo posebno prominentno kod njihove degranulisane &nbsp;subpopulacije. Stereolo&scaron;ka analiza je potvrdila histolo&scaron;ke nalaze.&nbsp;</p><p>Serumska analiza je pokazala uvećanu aktivnost aspartat aminotrasferaze (AST) i&nbsp;<br />smanjenu aktivnost alanin aminotrasferaze (ALT) kod obe grupe životinja tretiranih &nbsp;<br />akrilamidom u odnosu na kontrolu. Aktivnost alkalne fosfataze (ALP) je bila uvećana&nbsp;<br />u grupi tretiranoj nižom dozom, a smanjena u grupi tretiranoj većom dozom&nbsp;<br />akrilamida, u odnosu na kontrolu. Vrednosti koncentracije ukupnih serumskih proteina&nbsp;kao i koncentracije C reaktivnog proteina (CRP) nisu pokazale značajnije promene&nbsp;među eksperimentalnim grupama.</p><p>Oba akrilamidna tretmana su izazvala gubitak telesne mase kod tretiranih&nbsp;pacova, u odnosu na kontrolne životinje.&nbsp;Postojeći podaci ukazuju prominentni hepatotoksični potencijal akrilamida koji može&nbsp;poremetiti mikrostrukturne osobine i funkcionalni status hepatocita kod jetre mladog&nbsp;organizma. Akrilamid može značajno poremetiti funkcionalnost jetre, obzirom da se&nbsp;promene na celularnom nivou mogu relativno brzo odraziti na nivo tkiva, a kasnije&nbsp;ugroziti i homeostazu celog organizma.</p> / <p>Acrylamide&nbsp; (CASR No. 79-06- 1)&nbsp; is highly reactive, water-soluble monomer which is considered as toxic and potentially cancer causing chemical to humans. Adverse health effects regarding acrylamide and its more reactive metabolite,glycidamide, were detected in experimental animals, and&nbsp; included neurotoxicity, genotoxicity, and&nbsp;&nbsp; carcinogenicity.&nbsp; Human epidemiological studies claim that acrylamide has neurotoxic effects, while&nbsp; genotoxicity and carcinogenicity are considered as&nbsp; potential human health risks only on the basis of animal studies. Its harmful effects on the liver, especially in a young organism, are still to be elucidated.</p><p>Acrylamide&nbsp; is spontaneously formed in&nbsp; carbohydrate-rich food during high-temperature&nbsp; processing. It is&nbsp; formed during heat-induced non-enzymatic reaction, also known as&nbsp; the Maillard browning reaction, between reducing sugars (glucose and fructose), and free amino acids (mainly asparagine).</p><p>Having in mind&nbsp; that&nbsp; acrylamide&nbsp; metabolism takes place in a liver,&nbsp; the study aimed to investigate the main histological and&nbsp; biochemical changes in the liver of juvenile rat following subchronic acrylamide intoxication. Study was performed on peripubertal/juvenile male Wistar rats, divided in 3 experimental groups, two of which were treated with acrylamide in doses of 25 or 50 mg/kg of body weight, while the third group served as the control and received distilled water. Animals were treated orally, via gavage, 5 days a week, during 3 weeks. Animals&nbsp; were anesthetized by&nbsp;&nbsp; ether inhalation and decapitated 24 hrs after the last treatment.</p><p>Liver tissue was sampled from the middle lobe, fixed in&nbsp; 10% neutral&nbsp; buffered formalin for 24 hrs,&nbsp; routinely processed for paraffin&nbsp; embedding&nbsp; and cut into 5-&micro;m thick serial sections for subsequent histochemical and immunohistochemical staining.Blood samples were collected for subsequent biochemical analysis .</p><p>Histological examination of haematoxylin and eosin (H&amp;E) stained sections did not point to any major alteration in main in liver lobular architecture or organization among the experimental groups. Stereological analysis revealed a microstructural changes in hepatocytes and liver sinusoids. The analysis detected a dose-dependant increase in the volume of hepatocytes, their cytoplasm and nuclei, and dose-dependant decrease in the volume of liver sinusoids compared to the control, respectively.</p><p>Glycogen analysis was performed on Periodic acid&ndash;Schiff (PAS) stained sections which showed glycogen reduction in the low-dose group, and its accumulation in the high-dose group, compared to the control, respectively.</p><p>Imunopositivity in hepatocytes for Ki-67 protein, a known marker for proliferation, showed a decrease in low-dose group, while in high- dose group was detected its increase compared to the control, respectively. Stereological analysis confirmed initial histological observation.</p><p>Caspase 3 immunopositivity, a known marker for apoptosis, proved to be decreased in hepatocytes in both acrylamide-treated groups when compared to the control. One the other hand, immunopositivity was increased in non-parenchymal&nbsp; cell, predominantly in Kupffer cells, in comparison to the control. Immunopositivity for CD68, a marker for Kupffer cells, proved to be decreased in both acrylamide-treated groups when compared to the control.</p><p>Population of the mast cells, visualized on toluidine blue (TB) stained sections, showed its increase in both acrylamide-treated groups, in comparison to the control. The increase was especially prominent regarding a degranulated subpopulation of these cells. Subsequent stereological analysis confirmed histological findings.</p><p>Serum analysis showed increased&nbsp; activity of&nbsp; aspartate aminotransferase (AST), and decreased&nbsp; activity&nbsp; of alanine aminotransferase (ALT) in&nbsp; both AA-treated groups, while the&nbsp; activity&nbsp; of alkaline phosphatase (ALP)&nbsp; was increased in low-dose, but&nbsp;&nbsp; decreased in high- dose group compared to the control, respectively.&nbsp; The concentration of total serum proteins as well as concentration of C reactive protein (CRP) did not show any major changes among the experimental groups.</p><p>Body weight measurements showed that all acrylamide-treated rats lost their body weight as opposed to the control rats whose body mass increased.</p><p>Present results suggest a prominent hepatotoxic potential of acrylamide which might alter the microstructural features and functional status in hepatocytes of&nbsp; immature liver.&nbsp; Acrylamide may cause significant perturbation in liver functionality which may be reflected from cellular to the tissue level, thereby endangering the whole body&rsquo;s homeostasis.</p>

Identiferoai:union.ndltd.org:uns.ac.rs/oai:CRISUNS:(BISIS)100604
Date08 July 2016
CreatorsKovac Renata
ContributorsMatavulj Milica, Đolai Matilda, Ušćebrka Gordana
PublisherUniverzitet u Novom Sadu, Prirodno-matematički fakultet u Novom Sadu, University of Novi Sad, Faculty of Sciences at Novi Sad
Source SetsUniversity of Novi Sad
LanguageSerbian
Detected LanguageUnknown
TypePhD thesis

Page generated in 0.0031 seconds